Clamelle of Actavis awarded in the UK

At the annual SMaRT Awards last week in Birmingham, UK, Actavis were triumphant, winning Best POM to P Switch of the Year Award for Clamelle. The Clamelle training materials were also awarded Highly Commended in the Best Educational Initiative for Pharmacists category.

The SmaRT (Sales, Marketing and Retail Training) Awards, sponsored by Numark, exist to acknowledge the excellence of training initiatives and sales and marketing support programmes provided by drug manufacturers to pharmacists and their staff.

Best switch

Clamelle was awarded the title of Best POM to P switch in the pharmaceutical industry in 2008. Following the reclassification of azithromycin 500mg from prescription-only (POM) to pharmacy (P, OTC) medicine status, the Clamelle Chlamydia Test Kit and Clamelle Azithromycin 500mg tablets were launched in November 2008, under the banner of the Clamelle Chlamydia Service.

Competition in this category was fierce with Feminax Ultra (naproxen), Bayer and Voltarol (diclofenac), Novartis Consumer Health.

Excellent Educational Initiative

The Clamelle training materials which were prepared to support the launch of Clamelle were highly commended in this category. All UK pharmacists and pharmacy assistants received the training materials which were accredited by both NPA and CPP.